The Beauty Health CoSKIN
SKIN
0
Funds holding %
of 7,390 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
4,561% more call options, than puts
Call options by funds: $6.06M | Put options by funds: $130K
11% more capital invested
Capital invested by funds: $105M [Q3] → $116M (+$11.2M) [Q4]
0.13% more ownership
Funds ownership: 58.88% [Q3] → 59.01% (+0.13%) [Q4]
3% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 30
11% less funds holding
Funds holding: 114 [Q3] → 101 (-13) [Q4]
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
100% less funds holding in top 10
Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$1.50
12%
upside
Avg. target
$1.50
12%
upside
High target
$1.50
12%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Canaccord Genuity Susan Anderson 27% 1-year accuracy 10 / 37 met price target | 12%upside $1.50 | Hold Maintained | 13 Mar 2025 |
Financial journalist opinion
Neutral
Seeking Alpha
2 weeks ago
The Beauty Health Company (SKIN) Q4 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and Chief Executive Officer Mike Monahan - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Oliver Chen - TD Cowen Olivia Tong - Raymond James Ashley Helgans - Jefferies Jon Block - Stifel Navin Tsai - BNP Paribas Operator Good day and welcome to the Beauty Health Company Fourth Quarter and 2024 Full Year Earnings and Conference Call. [Operator Instructions] Please note this event is being recorded.

Neutral
GlobeNewsWire
2 weeks ago
BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results
LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 (“Q4 2024”).

Neutral
Business Wire
1 month ago
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Shareholders to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating The Beauty Health Company (NASDAQ: SKIN) (“Beauty Health”) on behalf of the company's shareholders. Click here for additional information: https://kaskelalaw.com/case/the-beauty-health-company/ Since March 2024, shares of Beauty Health's common stock have declined in value from a trading price of approximately $4.50 per share to a current trading price of below $1.75 per share, a decline of over 60% in value. The.

Neutral
Business Wire
3 months ago
BeautyHealth Appoints Stephen J. Fanning to Board of Directors
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, appoints medical aesthetics veteran, Stephen J. Fanning, to its Board of Directors.

Neutral
Business Wire
3 months ago
BeautyHealth Releases 2024 Skintuition Report
LONG BEACH, Calif.--(BUSINESS WIRE)--BeautyHealth Releases 2024 Skintuition Report.

Neutral
Business Wire
3 months ago
Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) f/k/a Vesper Healthcare Acquisition Corp.
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of The Beauty Health Company (NASDAQ: SKIN) f/k/a Vesper Healthcare Acquisition Corp. concerning the Company and its directors' and officers' possible violations of state laws. If you own Beauty Health stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230.

Neutral
Zacks Investment Research
4 months ago
Beauty Health (SKIN) International Revenue Performance Explored
Examine Beauty Health's (SKIN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Neutral
Seeking Alpha
4 months ago
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Oliver Chen - TD Cowen Ashley Helgans - Jefferies Allen Gong - JPMorgan Susan Anderson - Canaccord Genuity Bruce Jackson - Benchmark Company Jon Block - Stifel Linda Bolton Weiser - DA Davidson Korinne Wolfmeyer - Piper Sandler Olivia Tong - Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode.

Negative
Zacks Investment Research
4 months ago
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.

Neutral
Business Wire
4 months ago
BeautyHealth Reports Third Quarter 2024 Financial Results
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company reports third quarter 2024 financial results. Improved profitability reflects early success of strategic initiatives.

Charts implemented using Lightweight Charts™